Pharmaceuticals' innovation platform

Polish pharmaceutical companies have decided to join forces in their efforts to develop innovative medicine in the country. Under the patronage of the Ministry of Science and Information Society as well as the Health Ministry, they formed the Polish Technology Platform for Innovative Medicine.

The Platform's ideal is to be an effective basis for the development of research into advanced medicine. Its ultimate aim is to contribute to the invention of new, safe, and efficient drugs. Platform members hope that new medications will be created on the basis of Polish knowledge, with profits for patients and the country's economy.

"Innovative enterprising typically entails high risk, and the difficulties in winning funds for research  are a clear barrier for innovative companies. What is crucial for financing innovative activities is European Union funds, which should be also available to Polish companies," said director of the National Contact Point for EU Research Programs, Andrzej Siemaszko.

"We decided to act on behalf of the Platform because investment in R&D is an integrated part of our company's mission. We are convinced that searching for new medications is essential for the development of Polish pharmacy," said Maciej Adamkiewicz, president of Adamed, which has already entered the program.